1089P Hepcidin expression as a predictive biomarker for anti-PD1/PDL1 antibody monotherapy for advanced non-small cell lung cancer

Yamamoto, M. ; Kubo, S. ; Hirama, N. ; Teranishi, S. ; Tashiro, K. ; Seki, K. ; Maeda, C. ; Hiro, S. ; Kajita, Y. ; Sugimoto, C. ; Segawa, W. ; Nagayama, H. ; Nagaoka, S. ; Kudo, M. ; Kaneko, T.

Annals of oncology, 2022-09, Vol.33, p.S1049-S1050 [Periódico revisado por pares]

Texto completo disponível